BBNX Stock May Gain From Abbott Deal to Advance iLet Integration - MSN
2 days ago • Google News
Beta Bionics, Inc. Common Stock (BBNX)
US$ 10.393.38%
Price Chart
Key Statistics
Market Cap
$ 945.12M
P/E Ratio
0.00
Revenue (TTM)
$ 53.03M
Volume
177.53K
52W High
$ 24.50
52W Low
$ 8.89
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
22.8033
200-Day MA
22.8033
52 Week High
24.5
52 Week Low
8.89
About BBNX
Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring peo.
Employees
352
Headquarters
Irvine, CA
CEO
Mr. Sean T. Saint PE
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg